Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides

Por Yang, Yong, Ji, Shundong, Liu, Shuang
Publicado em 2014

Evaluation of K(HYNIC)(2) as A Bifunctional Chelator for (99m)Tc-Labeling of Small Biomolecules

Por Ji, Shundong, Zhou, Yang, Shao, Guoqiang, Liu, Shuang
Publicado em 2013

Development of Kit Formulations for (99m)TcN-MPO: A Cationic Radiotracer for Myocardial Perfusion Imaging

Por Zheng, Yumin, Ji, Shundong, Tomaselli, Elena, Liu, Shuang
Publicado no J Labelled Comp Radiopharm (2014)

Integrin α(v)β(3)-Targeted Radiotracer (99m)Tc-3P-RGD(2) Useful for Noninvasive Monitoring of Breast Tumor Response to Antiangiogenic Linifanib Therapy but not Anti-Integrin α(v)β(...

Por Ji, Shundong, Zheng, Yumin, Shao, Guoqiang, Zhou, Yang, Liu, Shuang
Publicado em 2013

FITC-Conjugated Cyclic RGD Peptides as Fluorescent Probes for Staining Integrin α(v)β(3)/α(v)β(5) in Tumor Tissues

Por Zheng, Yumin, Ji, Shundong, Czerwinski, Andrzej, Valenzuela, Francisco, Pennington, Michael, Liu, Shuang
Publicado no Bioconjug Chem (2014)

Effect of Co-Ligands on Chemical and Biological Properties of (99m)Tc(III) Complexes [(99m)Tc(L)(CDO)(CDOH)(2)BMe] (L = Cl, F, SCN and N(3); CDOH(2) = Cyclohexanedione Dioxime)

Por Zheng, Yumin, Ji, Shundong, Tomaselli, Elena, Ernest, Carley, Freiji, Tom, Liu, Shuang
Publicado no Nucl Med Biol (2014)

(99m)Tc-Galacto-RGD(2): A Novel (99m)Tc-Labeled Cyclic RGD Peptide Dimer Useful for Tumor Imaging

Por Ji, Shundong, Czerwinski, Andrzej, Zhou, Yang, Shao, Guoqiang, Valenzuela, Francisco, Sowiński, Pawél, Chauhan, Satendra, Pennington, Michael, Liu, Shuang
Publicado em 2013

Monitoring Tumor Response to Linifanib Therapy with SPECT/CT Using the Integrin α(v)β(3)–Targeted Radiotracer (99m)Tc-3P-RGD(2)

Por Ji, Shundong, Zhou, Yang, Voorbach, Martin J., Shao, Guoqiang, Zhang, Yumin, Fox, Gerard B., Albert, Daniel H., Luo, Yanping, Liu, Shuang, Mudd, Sarah R.
Publicado em 2013

Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer

Por Ji, Cheng, Zhang, Li, Cheng, Yan, Patel, Raj, Wu, Hao, Zhang, Yi, Wang, Mian, Ji, Shundong, Belani, Chandra P, Yang, Jin-Ming, Ren, Xingcong
Publicado em 2014